Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IDEntification of New Predisposition Genes in Differentiated THYroid Cancer

NCT05014698 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT05014698
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05014698 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IDEntification of New Predisposition Genes in Differentiated THYroid Cancer
Lead sponsor
Nantes University Hospital
Phase
Not applicable
Overall status
Terminated
Start date
February 23, 2022
Completion date
January 13, 2026
Enrollment
34 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

differentiated thyroid cancer, thyroid cancer, nonmedullary